Pulse Biosciences (PLSE) Notes Payables (2021 - 2023)

Pulse Biosciences has reported Notes Payables for 3 years, with the latest figure at $801000.0 in Q1 2023.

• For the quarter ending Q1 2023, Notes Payables changed N/A year-over-year to $801000.0; the trailing twelve-month figure through Mar 2023 stood at $801000.0 (changed N/A YoY), and the FY2022 full-year result was $917000.0, up 110.32% from the prior year.
• Notes Payables for Q1 2023 stood at $801000.0, down from $917000.0 in the prior quarter.
• The five-year high for Notes Payables was $1.7 million in Q2 2021, with the low at $98000.0 in Q3 2022.
• Average Notes Payables over 3 years is $740857.1, with a median of $801000.0 recorded in 2023.
• Peak annual rise in Notes Payables reached 110.32% in 2022, while the deepest fall reached 90.98% in 2022.
• Tracing PLSE's Notes Payables over 3 years: stood at $436000.0 in 2021, then surged by 110.32% to $917000.0 in 2022, then retreated by 12.65% to $801000.0 in 2023.
• The last three Notes Payables figures came in at $801000.0 (Q1 2023), $917000.0 (Q4 2022), and $98000.0 (Q3 2022), per Business Quant data.

Peer Comparison